REFERENCES
- Alter , M. J. , Kruszon-Moran , D. , Nainan , O. V. , McQuillan , G. M. , Gao , F. , Moyer , L. A. , Kaslow , R. A. and Margolis , H. S. 1999 . The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 . N. Engl. J. Med. , 341 : 556 – 562 .
- Collier , J. and Chapman , R. 2001 . Combination therapy with interferon-alpha and ribavirin for hepatitis C: practical treatment issues . BioDrugs , 15 : 225 – 238 .
- Di Bisceglie , A. M. , McHutchison , M. J. and Rice , C. M. 2002 . New therapeutic strategies for hepatitis C . Hepatology , 285 : 224 – 231 .
- Wang , P. Y. , Hollecker , L. , Pankiewicz , K. P. , Patterson , S. E. , Whitaker , T. , McBrayer , T. R. , Tharnish , P. M. , Sidwell , R. W. , Stuyver , L. J. , Otto , M. J. , Schinazi , R. F. and Watanabe , K. A. 2004 . Synthesis of N 3,5′-cyclo-4-(β-D-ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one, a novel compound with potential anti-hepatitis C virus activity . J. Med. Chem. , in press
- Wang , P. Y. , Hollecker , L. , Pankiewicz , K. P. , Patterson , S. E. , Whitaker , T. , McBrayer , T. R. , Tharnish , P. M. , Stuyver , L. J. , Otto , M. J. , Schinazi , R. F. and Watanabe , K. A. Synthesis of N 3,5′-cyclo-4-(β-D-ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one and its 3′-deoxy analogue as potential anti-hepatitis C virus agents . Nucleosides Nucleotides Nucleic Acids , in press
- Sasaki , T. , Minamoto , K. , Kino , M. and Mizuno , T. 1976 . Reactions of the derivatives of 5-bromopyrimidine nucleosides with sodium azide . J. Org. Chem. , 41 : 1100 – 1104 .
- Stuyver , L. J. , McBrayer , T. R. , Tharnish , P. M. , Hassan , A. E.A. , Chu , C. K. , Pankiewicz , K. W. , Watanabe , K. A. , Schinazi , R. F. and Otto , M. J. 2003 . Dynamics of subgenomic hepatitis C virus replicon RNA levels in Huh cells after exposure to nucleotide anti-metabolites . J. Virol. , 77 : 10689 – 10694 .